Karl-Heniz Thierauch

Title: The Innovations of Karl-Heniz Thierauch

Introduction

Karl-Heniz Thierauch is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. His work focuses on innovative solutions that target diseases associated with persistent angiogenesis.

Latest Patents

Thierauch holds a patent for "N-oxide anthranylamide derivatives and their use as medicaments." This patent describes substituted N-oxidanthranilamide derivatives, their production, and their application as pharmaceutical agents. These compounds are particularly useful in treating diseases such as psoriasis, Kaposi's sarcoma, and various forms of cancer, including leukemia and Hodgkin's disease. Additionally, they have applications in treating eye diseases, renal diseases, fibrotic diseases, and as immunosuppressive agents.

Career Highlights

Thierauch is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work has led to advancements in the treatment of conditions that involve complex biological processes, showcasing his expertise in medicinal chemistry and pharmacology.

Collaborations

Thierauch has collaborated with notable colleagues, including Alexander Ernst and Andreas Huth. These partnerships have contributed to the development and refinement of his innovative pharmaceutical compounds.

Conclusion

Karl-Heniz Thierauch's contributions to the field of medicine through his patented innovations demonstrate his commitment to improving healthcare outcomes. His work continues to influence the development of effective treatments for various diseases.